Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

PCWG4 updates recommendations on patient and tumor characterization, therapy development, and imaging criteria and extends guidance into earlier androgen pathway modulator-naïve/sensitive disease states to reflect an evolving, heterogeneous, and diverse patient population to optimize treatment benefits for all patients.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-02-26
DOI
https://doi.org/10.1200/jco-25-02834
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
36.44
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

Dana E. Rathkopf, Joshua M. Lang, Charles J. Ryan, Daniel E. Lage et al.
1 citations
Journal of Clinical Oncology
Prostate Cancer Treatment and Research
36.44
article

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

Dana E. Rathkopf, Joshua M. Lang, Charles J. Ryan, Daniel E. Lage, M. Morris, Heiko M. Schöder, Daniel S. Childs, Delphine L. Chen, William L. Dahut, P. Nelson, Alan Haruo Bryce, Ken Hermann, Nima Sharifi, Julie N. Graff, Elizabeth Riley Kessler, Susan F. Slovin, Matthew B. Rettig, M. Stein, Louise Emmett, Kristofer Prepelica, Nadine Mallak, Kosj Yamoah, Anis Hamid, Nicholas Zorko, Glenn X. Liu, Channing Judith Paller, N. Kim., Alex Wyatt, Maha Hussain, Lauren Schwartz, MD Thomas A. Hope, Pedro C. Barata, Phillip H. Kuo, Alexandra O. Sokolova, Ana Aparicio, Andrei Gafita, S. Halabi, Wassim Abida, Cora N. Sternberg, Evan Y. Yu, Michael A. Carducci, Andrew J. Armstrong, Charles G. Drake, Emmanuel S. Antonarakis, David Nanus, Alicia K. Morgans, Catherine H. Marshall, Joshi J. Alumkal, Scott T. Tagawa, Akash Patnaik, Howard I. Scher, for the PCWG4 Writing Group, Michael S. Hofman, Jones Nauseef, Daniel J. George, Karim Fizazi, Rana R. McKay, W. Kevin Kelly, Russell Z. Szmulewitz, Mary-Ellen Taplin, Zachery R. Reichert, Heather H. Cheng, Himisha Beltran, Walter M. Stadler, A. Oliver Sartor, Elisabeth I. Heath, Rahul R. Aggarwal
article en
1 citations

Abstract

PCWG4 updates recommendations on patient and tumor characterization, therapy development, and imaging criteria and extends guidance into earlier androgen pathway modulator-naïve/sensitive disease states to reflect an evolving, heterogeneous, and diverse patient population to optimize treatment benefits for all patients.

Journal of Clinical Oncology
Northwestern University (US), American Cancer Society (US), BC Cancer Agency (CA), City Of Hope National Medical Center (US), University of Minnesota (US), Memorial Sloan Kettering Cancer Center (US), University of Wisconsin–Madison (US), University of British Columbia (CA), Johns Hopkins University (US), University of Miami (US), Thomas Jefferson University (US), Oregon Health & Science University (US), The University of Melbourne (AU), Duke University (US), University of California, San Francisco (US), University of Washington (US), Cornell University (US), University of Michigan (US), Columbia University Irving Medical Center (US), Johns Hopkins Medicine (US), Peter MacCallum Cancer Centre (AU), Institut Gustave Roussy (FR), Moffitt Cancer Center (US), University of California San Diego (US), University of Chicago (US), St Vincent's Hospital Sydney (AU), Hope Cancer Clinic (US), London Cancer (GB), James A. Haley Veterans' Hospital (US), Fred Hutch Cancer Center (US), Presbyterian Hospital (US), University of Wisconsin Carbone Cancer Center (US), Sidney Kimmel Cancer Center (US), City of Hope (US), Prostate Cancer Research (GB), Dana-Farber Cancer Institute (US), Essen University Hospital (DE), Mayo Clinic in Arizona (US), Duke Medical Center (US), Canada's Michael Smith Genome Sciences Centre (CA), Goodyear (United States) (US), Duke University Hospital (US), Sidney Kimmel Comprehensive Cancer Center (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), Weill Cornell Medicine (US), University College London (GB), University of Colorado Denver (US)
Good health and well-being, Partnerships for the goals
Openalex Percentile: Top 0%
Prostate Cancer Treatment and Research
36.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.